(0.32%) 5 116.18 points
(0.30%) 38 356 points
(0.37%) 15 987 points
(-0.95%) $83.05
(5.41%) $2.03
(0.36%) $2 355.60
(0.54%) $27.68
(4.23%) $961.15
(-0.27%) $0.932
(-0.44%) $10.98
(-0.58%) $0.796
(1.63%) $93.37
@ $1.237
発行日: 14 2月 2024 @ 23:30
リターン: -32.27%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -0.24 %
Live Chart Being Loaded With Signals
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight...
Stats | |
---|---|
本日の出来高 | 577 403 |
平均出来高 | 1.53M |
時価総額 | 51.29M |
EPS | $0 ( 2024-03-05 ) |
次の収益日 | ( $-0.870 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.00200 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-15 | Chaubey Alka | Sell | 1 081 | Common Stock |
2024-02-15 | Oldakowski Mark | Sell | 1 229 | Common Stock |
2024-02-15 | Holmlin R. Erik | Sell | 3 073 | Common Stock |
2024-02-15 | Dixon Jonathan V. | Sell | 402 | Common Stock |
2023-09-18 | Oldakowski Mark | Buy | 20 000 | Common Stock |
INSIDER POWER |
---|
83.54 |
Last 99 transactions |
Buy: 20 105 134 | Sell: 833 309 |
ボリューム 相関
Bionano Genomics Inc 相関
10 最も負の相関 | |
---|---|
BRIVU | -0.974 |
TIOA | -0.96 |
VLAT | -0.957 |
BRIV | -0.956 |
MSDA | -0.953 |
MSDAU | -0.953 |
TIOAU | -0.952 |
LDHA | -0.947 |
HEWG | -0.945 |
OMAB | -0.945 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Bionano Genomics Inc 相関 - 通貨/商品
Bionano Genomics Inc 財務諸表
Annual | 2023 |
収益: | $36.12M |
総利益: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2023 |
収益: | $36.12M |
総利益: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2022 |
収益: | $27.80M |
総利益: | $5.95M (21.38 %) |
EPS: | $-4.58 |
FY | 2021 |
収益: | $17.98M |
総利益: | $3.87M (21.54 %) |
EPS: | $-0.260 |
Financial Reports:
No articles found.
Bionano Genomics Inc
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。